Neurological Therapeutics
Online ISSN : 2189-7824
Print ISSN : 0916-8443
ISSN-L : 2189-7824
 
Review/Advances in neurological therapeutics (2017). Immune–mediated central nervous system disorders
Hiroshi Kuroda
Author information
Keywords: multiple sclerosis, progressive multiple sclerosis, no evidence of disease activity, neuromyelitis optica, myelin oligodendrocyte glycoprotein
JOURNAL FREE ACCESS

2018 Volume 35 Issue 5 Pages 598-600

Details
Download PDF (333K)
Download citation RIS

(compatible with EndNote, Reference Manager, ProCite, RefWorks)

BIB TEX

(compatible with BibDesk, LaTeX)

Text
How to download citation
Contact us
Abstract

Recent advances and new findings relating to multiple sclerosis (MS) and related disorders were reviewed. We adopted the studies regarding an effective treatment for progressive MS, composite endpoints in MS clinical trials, risks for progressive multifocal leukoencephalopathy caused by fingolimod and fumarate, a clinical trial on neuromyelitis optica (NMO), and clinical spectrum of myelin oligodendrocyte glycoprotein (MOG) antibody–positive disorders.

Content from these authors
© 2018 Japanese Society of Neurological Therapeutics
Previous article Next article
Favorites & Alerts

Recently viewed articles
Share this page
feedback
 Top